制图：佘诗婕 星标 ★ IPO日报 精彩文章第一时间推送 据IPO日报汇总，3月24日至3月30日，即上周一周内，多家上市公司发布发行可转债募资公告。其中，3月28日，三友化工（600409.SH）拟公开发 行公司债券，规模不超过9亿元，美力科技（300611.SZ）拟发行可转债募资不超过3亿元。 另外，3月28日，上交所和深交所修订并发布了《上海证券交易所公司债券发行上市审核规则适用指引第3号——审核重点关注事项（2025年修订）》、 《深圳证券交易所公司债券发行上市审核业务指引第2号——审核重点关注事项（2025年修订）》，旨在进一步强化公司债券（含企业债券）发行准入监 管，提升审核透明度，推动市场高质量发展。 3月24日至3月30日发债情况汇总 制图：李昕 三家5年内多次募资 上周，多家上市公司发布公告，拟通过发行可转换债券募资，涵盖新能源汽车、跨境电商、机器人等领域，IPO日报整理发现，无锡振华 （605319.SH）、瑞鹄模具（002997.SZ）和双乐股份（301036.SZ）均为上市5年内多次募资。目前无锡振华发行可转债申请获上交所通过。 3月26日，无锡振华公告称，公司向不特定对象发行可转换公 ...

证券代码：688199 证券简称：久日新材 公告编号：2025-014 天津久日新材料股份有限公司 ? 股东大会召开日期：2025年4月17日 ? 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 一、召开会议的基本情况 关于召开 2025 年第一次临时股东大会的通知 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： （一）股东大会类型和届次 （二）股东大会召集人：董事会 （三）投票方式：本次股东大会所采用的表决方式是现场投票和网络投票相 结合的方式 （四）现场会议召开的日期、时间和地点 召开日期时间：2025 年 4 月 17 日 14 点 30 分 （七）涉及公开征集股东投票权 不适用。 二、会议审议事项 本次股东大会审议议案及投票股东类型 召开地点：天津市华苑新技术产业园区工华道 1 号智慧山 C 座贰门五层公司 会议室 （五）网络投票的系统、起止日期和投票时间 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自 2025 年 4 月 17 日 至 2025 年 4 ...

Core Viewpoint - Tangshan Sanyou Chemical Co., Ltd. plans to issue corporate bonds not exceeding RMB 900 million to professional investors, pending approval from the shareholders' meeting and the China Securities Regulatory Commission [1][2]. Group 1: Bond Issuance Overview - The bond issuance scale is set at a maximum of RMB 900 million, which may be issued in a single or multiple tranches [1][2]. - The bonds will have a face value of RMB 100 and a term of no more than 3 years, with the specific terms to be determined based on market conditions and the company's funding needs [2]. - The bonds will be issued at par value and will not be preferentially allocated to existing shareholders [2][3]. Group 2: Use of Proceeds - The proceeds from the bond issuance will be used for various purposes, including repaying maturing corporate bonds, repaying bank loans, and supplementing working capital [3][4]. - The company will seek to list the bonds on the Shanghai Stock Exchange after meeting the listing conditions [3][4]. Group 3: Financial Information - As of September 2024, the company's total assets amounted to RMB 2,615.19 million, with total liabilities of RMB 1,091.11 million and total equity of RMB 1,524.07 million [6][8]. - The company's operating revenue for the first nine months of 2024 was RMB 1,607.79 million, with total operating costs of RMB 1,543.63 million [8][9]. - The net profit for the first nine months of 2024 was RMB 55.03 million, with basic and diluted earnings per share of RMB 0.1912 [9].

Core Viewpoint - China Sanjiang Chemical (02198) reported a significant increase in revenue and profit for the fiscal year ending December 31, 2024, with total revenue reaching RMB 19.586 billion, a year-on-year growth of 49.2%, and a net profit attributable to shareholders of RMB 533 million, up 482.2% [1] Group 1: Business Performance - The company observed signs of stable and gradual recovery in its major business lines, particularly in ethylene glycol, butadiene, ethylene oxide, and surfactants, with polypropylene also showing positive momentum [1] - Ethylene glycol experienced a notable rebound in 2024, with average prices rising approximately 9.7% compared to 2023, reaching about RMB 3,986 per ton, and sales volume increasing by about 84.6% to 868,951 tons, making it one of the best-performing segments [1] - The rebound in ethylene glycol was driven by a stable domestic consumption and a recovery in the textile and apparel industry, alongside supply adjustments due to low-margin coal-based production [1] Group 2: Butadiene and Ethylene Oxide - Butadiene saw a strong rebound in 2024, with average prices increasing by approximately 51.0% to about RMB 10,267 per ton, and sales volume rising by about 105.2% to approximately 74,732 tons [2] - The growth in butadiene was primarily driven by increased demand from the automotive manufacturing sector and supply shortages due to unexpected power outages in South Korea and Japan [2] - The ethylene oxide segment also showed positive developments, with average prices rising about 5.6% to approximately RMB 5,993 per ton, reversing a downward trend observed in previous years [2][3] Group 3: Surfactants and Polypropylene - The surfactants business line saw a sales increase of approximately 45.6% compared to 2023, as the company focused on vertical integration to mitigate market risks and enhance profit margins [3] - Polypropylene maintained stable pricing in 2024 at around RMB 6,448 per ton, with a slight increase in downstream demand contributing to price stability [3] - The overall gross margin improved from 1.5% in 2023 to approximately 5.7% in 2024, attributed to enhanced production efficiency and cost-effectiveness following successful capacity increases in previous years [3]

Core Insights - Hengguang Co., Ltd. experienced a trading halt with a daily price increase of 20.00% and a turnover rate of 11.23% [2] - The total trading volume for the day reached 266 million yuan, with a price fluctuation of 10.18% [2] - Institutional investors showed a net selling of 454,100 yuan, while brokerage seats collectively recorded a net buying of 29.95 million yuan [2] Trading Data - The top five brokerage seats accounted for a total transaction volume of 67.93 million yuan, with buying transactions amounting to 48.71 million yuan and selling transactions at 19.21 million yuan, resulting in a net buying of 29.50 million yuan [2] - Among the brokerage seats, three institutional specialized seats were involved, with a total buying amount of 9.56 million yuan and selling amount of 10.01 million yuan, leading to a net selling of 454,100 yuan [2] Fund Flow - The stock saw a net inflow of 61.23 million yuan from major funds, with a significant single order net inflow of 85.19 million yuan, while large orders experienced a net outflow of 23.96 million yuan [2] - Over the past five days, the net inflow of major funds totaled 53.04 million yuan [2]

Core Viewpoint - Kunming Chuanjin Nuo Chemical Co., Ltd. has announced the progress of cash management using idle raised funds, with a total amount not exceeding 400 million RMB approved for use within a 12-month period [1]. Group 1: Cash Management Approval - The company held its fifth board meeting on June 20, 2024, where it approved the use of idle raised funds for cash management [1]. - The approved amount for cash management is capped at 400 million RMB, which can be used in a rolling manner over the next 12 months [1]. Group 2: Redemption of Financial Products - Several financial products purchased with idle funds have reached maturity and have been redeemed [1]. - The company has provided details on the redeemed financial products, including the type, amount, and expected annualized returns [1]. Group 3: Financial Product Details - One of the redeemed products was a fixed-rate deposit certificate from China Merchants Bank, with a principal of 50 million RMB and an annualized return of 1.8% [1]. - Another product was a structured floating income product from Shenwan Hongyuan Securities, with a principal of 36 million RMB and an expected annualized return of 1.75% [1].

Summary of Key Points Core Viewpoint - The company plans to provide a total guarantee of up to 1.2133 billion yuan for its subsidiaries to support their project development and operational needs, with some subsidiaries having a debt-to-asset ratio exceeding 70% by the end of 2024 [1][2]. Group 1: Guarantee Overview - The company’s board approved a proposal to provide guarantees for its wholly-owned and controlling subsidiaries, including Guang'an Luyuan, Sichuan Foresun, Hubei Litai, and others [1][2]. - The total amount of guarantees proposed is capped at 1.2133 billion yuan, which will be used for bank credit applications by the subsidiaries [2]. Group 2: Subsidiary Information - Guang'an Luyuan focuses on resource recycling and chemical product sales, with a debt-to-asset ratio exceeding 70% [2][4]. - Sichuan Foresun is involved in chemical product sales and related equipment sales [5]. - Hubei Litai specializes in pesticide production and sales, along with chemical product manufacturing [6]. - Lier Crop Science engages in agricultural product sales and technology services [7]. - Lier Biotechnology is involved in the production of food additives and pharmaceuticals [8]. - Qiming Star Huachuang focuses on the production and sales of non-hazardous chemical products [9]. - Baidian Biotechnology operates in agricultural technology services and chemical product sales [10]. - Saike Chemical is engaged in the production and sales of chemical products and raw materials [11]. - Bide Biochemical specializes in chemical product production and bio-pesticide technology research [12]. Group 3: Guarantee Agreement Details - The company will sign guarantee agreements for the credit limits applied by the subsidiaries, assuming joint liability for the guarantees [10]. - The board believes that providing these guarantees aligns with regulatory requirements and supports the subsidiaries' operational growth, benefiting the overall company [10][12]. Group 4: Cumulative Guarantee Situation - As of the announcement date, the total approved guarantee amount, including this proposal, is 5.5333 billion yuan, accounting for 71.61% of the company's audited net assets as of the end of 2024 [12].

中泰证券股份有限公司 关于山东联科科技股份有限公司 2024 年度内部控制评价报告的核查意见 中泰证券股份有限公司（以下简称"中泰证券"或"保荐机构"）作为山东 联科科技股份有限公司（以下简称"联科科技"或"公司"）2023 年度以简易程 序向特定对象发行股票并在深圳证券交易所主板上市及进行持续督导的保荐机 构，根据《证券发行上市保荐业务管理办法》《深圳证券交易所股票上市规则》 《深圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规范运作》等 有关规定，对公司 2024 年度内部控制自我评价报告进行核查并出具核查意见， 具体情况如下： 一、内部控制评价工作情况 内部控制评价范围 公司按照风险导向原则确定纳入评价范围的主要单位、业务和事项以及高风 险领域。 1、纳入评价范围的主要单位 | 序号 | 公司名称 | 与公司关系 | 股权比例 | | --- | --- | --- | --- | | 1 | 山东联科科技股份有限公司 | 本部 | - | | 2 | 山东联科新材料有限公司 | 子公司 | 99.75 | | 3 | 山东联科化工有限公司 | 子公司 | 98.51 | | 4 | 山东联 ...

Core Viewpoint - The company reported a significant increase in both revenue and net profit for the fiscal year 2024, indicating strong operational performance and growth potential in the industry [2]. Group 1: Financial Performance - In 2024, the company achieved an operating revenue of 47.4 billion yuan, a year-on-year increase of 14% [2] - The net profit attributable to shareholders reached 6.1 billion yuan, reflecting a year-on-year growth of 27% [2] - In Q4 alone, the company generated 15.2 billion yuan in revenue, marking a 42% increase year-on-year and an 18% increase quarter-on-quarter [2] - The net profit for Q4 was 2.4 billion yuan, showing a remarkable year-on-year growth of 71% and a quarter-on-quarter increase of 46% [2] Group 2: Industry Chain and Project Developments - The profitability of the C3 industry chain has significantly improved, contributing to the substantial growth in Q4 performance [3] - The company successfully launched its multi-carbon alcohol project, which includes a production capacity of 400,000 tons of various chemical materials, enhancing the integration of the C3 industry chain [4] - The α-olefin comprehensive utilization project has commenced construction, which is expected to secure the company's long-term growth by producing high-end new materials [5] - The first phase of the α-olefin project is anticipated to be completed by the end of 2025, with further phases planned for completion in 2026 [5]

该额度的有效期自 2024 年年度股东大会审议通过之日起至 2025 年年度股东大 会召开日止，在授信期限内，额度可循环使用。具体融资金额将视公司运营资金的 实际需求来确定，以银行与公司实际发生的融资金额为准。 证券代码：001207 证券简称：联科科技 公告编号：2025-010 山东联科科技股份有限公司 关于公司及子公司 2025 年度拟向银行等金融机构 申请综合授信额度的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 山东联科科技股份有限公司（以下简称"公司"）于 2025 年 2 月 27 日召开了 第三届董事会第二次会议，审议通过了《关于公司及子公司 2025 年度拟向银行等 金融机构申请综合授信额度的议案》。本议案尚需提交公司股东大会审议，现将有 关情况公告如下： 一、拟申请授信额度情况 为满足公司及子公司生产经营和发展需要，2025 年度公司及子公司拟向银行申 请不超过人民币 20 亿元（含 20 亿元；其中敞口授信 13 亿元，低风险授信 7 亿元） 的综合授信额度，包括但不限于流动资金贷款、非流动资金贷款、承兑汇票、保理、 保函、开立信 ...